Monograph was founded to invest in life sciences companies that seek to create new or improved therapeutics, diagnostics and related technology-enabled business services which enhance healthcare outcomes. With primary offices in London, San Francisco and Dallas-Fort Worth, Monograph bridges opportunities across North America, the United Kingdom and Europe, bringing deep experience, relationships, and capabilities to help these companies scale.